Purchases and Sales Made in Q2 2024 in Cue Biopharma, Inc. (CUE)
This table provides information about the institutional ownership of Cue Biopharma, Inc. (CUE) during Q2 2024. The information is specifically focused on institutions that hold shares of Cue Biopharma, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2024
Q2 2024
|
Charles Schwab Investment Management Inc
San Francisco, CA |
SELL
|
- |
-74.5K- 81.35% |
$92.3K - $162K
|
17.1K
$15.7K
|
|
|
Aug 07, 2024
Q2 2024
|
Monaco Asset Management Sam
|
SELL
|
- |
-81.6K- 24.36% |
$101K - $178K
|
253K
$233K
|
|
|
Aug 09, 2024
Q2 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-217K- 50.36% |
$269K - $474K
|
214K
$197K
|
|
|
Aug 13, 2024
Q2 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-252K- 11.03% |
$312K - $549K
|
2.03M
$1.87M
|
|
|
Aug 09, 2024
Q2 2024
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-346K- 41.27% |
$429K - $754K
|
492K
$453K
|
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-583K- 76.7% |
$723K - $1.27M
|
177K
$163K
|
|
|
Aug 13, 2024
Q2 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-1.49M- 66.28% |
$1.84M - $3.24M
|
757K
$696K
|